Amag Pharmaceuticals (AMAG)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 12-2014 | 12-2013 | 12-2012 | 12-2011 | 12-2010 | |
| Sales | 124,384 | 80,856 | 85,378 | 61,249 | 66,245 |
| Cost of Goods | 20,306 | 11,960 | 14,220 | 10,531 | 7,606 |
| Gross Profit | 104,078 | 68,896 | 71,158 | 50,718 | 58,639 |
| Operating Expenses | 108,221 | 81,473 | 88,802 | 131,042 | 142,231 |
| Operating Income | -3,837 | -11,617 | -17,424 | -79,793 | -82,986 |
| Interest Expense | 14,697 | 0 | 0 | 0 | 0 |
| Other Income | 1,192 | 2,015 | -180 | 1,554 | 1,361 |
| Pre-tax Income | -17,342 | -9,602 | -17,604 | -78,239 | -81,625 |
| Income Tax | -153,159 | 0 | -854 | -1,170 | -472 |
| Net Income Continuous | 135,817 | -9,602 | -16,750 | -77,069 | -81,153 |
| Net Income | $135,817 | $-9,602 | $-16,750 | $-77,069 | $-81,153 |
| EPS Basic Total Ops | 6.06 | -0.44 | -0.78 | -3.64 | -3.90 |
| EPS Basic Continuous Ops | 6.06 | -0.44 | -0.78 | -3.64 | -3.90 |
| EPS Diluted Total Ops | 5.45 | -0.44 | -0.78 | -3.64 | -3.90 |
| EPS Diluted Continuous Ops | 5.38 | -0.44 | -0.78 | -3.64 | -3.90 |
| EPS Diluted Before Non-Recurring Items | -0.17 | N/A | N/A | N/A | N/A |
| EBITDA(a) | $12,097 | $-5,774 | $-11,532 | $-73,618 | $-78,902 |